Iovance Biotherapeutics Reports FDA Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma

Iovance Biotherapeutics Reports FDA Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma

The Experts in Investor and Public Relations

Beamr Moving on NVIDIA CABR Integration News

Kubient and Adomni to Merge

USPTO Issues Notice of Allowance to Enveric Biosciences for C4-Carboxylic Acid-Substituted Tryptamine Derivatives

GigaCloud Technology Reaches Highest Profitability in the Company’s History in Q1 2023

Top Premarket Momos for 23 May 2023

Ocean Biomedical Awarded Patent for Novel Cancer Immunotherapy Treatment

Lifecore Biomedical Closes $150 Million New Financing Agreement and Signs New HA Fermentation Capacity Supply Agreement

Top Premarket Momos for 22 May 2023

Hepion Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 2 Study

Microbot Medical’s LIBERTY Achieves 100% Success Rate in Extensive Pre-Clinical Animal Study Performed in Europe

MIND Technology Receives Source Controller Order

Aligos Therapeutics Enters Research Collaboration and Development Agreement with Xiamen Amoytop Biotech

Top Premarket Momos for 12 May 2023

OppFi Raises Full-Year Earnings Outlook after Exceeding Q1 2023 Profitability Guidance

ARS Pharmaceuticals Receives Favorable FDA Advisory Committee Vote

Wearable Devices’ Mudra Bands are Now Compatible with RealWear and Nreal Smart Glasses

Top Premarket Momos for 11 May 2023

New England Journal of Medicine Publishes DBV Technologies’ Phase 3 EPITOPE Trial Data Evaluating Viaskin Peanut in Toddlers

Sunshine Biopharma Q1 Revenues Up 2,100%

Polar Power Targeting Q1 2024 Rollout for New Line of Mobile Electric Vehicle Chargers

24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

© 2022-2023 24/7MarketNews – The Experts in Investor and Public Relations